Loading insider details...
Beta
Latest Form 4 (Sep 17, 2026): Grant/Award of 1,187 KRYS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 17, 2026 | Krystal Biotech, Inc. (KRYS) | Grant/Award | 1,187 | n/a |
| Oct 3, 2025 | Outlook Therapeutics, Inc. (OTLK) | Grant/Award | 286,734 | n/a |
| Jun 30, 2025 | Krystal Biotech, Inc. (KRYS) | Grant/Award | 5,000 | n/a |
| Oct 4, 2024 | Outlook Therapeutics, Inc. (OTLK) | Grant/Award | 56,636 | n/a |
| Jul 1, 2024 | Krystal Biotech, Inc. (KRYS) | Grant/Award | 5,000 | n/a |
| May 22, 2024 | Krystal Biotech, Inc. (KRYS) | Exercise/Conversion | 20,000 | $455.0K |
| May 3, 2024 | Revance Therapeutics, Inc. (RVNC) | Grant/Award | 15,000 | n/a |
| Mar 8, 2024 | Outlook Therapeutics, Inc. (OTLK) | Grant/Award | 94,441 | n/a |
| Oct 6, 2023 | Outlook Therapeutics, Inc. (OTLK) | Grant/Award | 370,282 | n/a |
| Jul 3, 2023 | Krystal Biotech, Inc. (KRYS) | Grant/Award | 6,800 | n/a |